Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Avista Pharma Solutions, Inc.
FDA Inspection
•Avista Pharma Solutions, Inc.•September 27, 2013

Avista Pharma Solutions, Inc. – FDA Inspection, Sep 27, 2013

Record Details

This FDA Inspection record concerns Avista Pharma Solutions, Inc., with an inspection on September 27, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Avista Pharma Solutions, Inc.
Inspection Date
September 27, 2013
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · 51fdbe29-4c8a-4db0-b664-5ef7edf67340

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
850250
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

8
  1. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  2. 21 CFR 211.113(b)Validation lacking for sterile drug products
  3. 21 CFR 211.84(d)(2)Reports of Analysis (Components)
  4. 21 CFR 211.42(c)(10)Aseptic Processing Area
  5. 21 CFR 211.165(a)Testing and release for distribution
  6. 21 CFR 211.160(a)Lab controls established, including changes
  7. 21 CFR 211.100(a)Absence of Written Procedures
  8. 21 CFR 211.192Investigations of discrepancies, failures

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Avista Pharma Solutions, Inc.

6
DateClassificationOfficeProject area
August 14, 2026Not classifiedNew England District OfficeHuman Cellular, Tissue, and Gene Therapies
July 25, 2025VAINew England District OfficeDrug Quality Assurance
December 18, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 5, 2018NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
June 15, 2016VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 6 other inspections on the company page
Other documents for Avista Pharma Solutions, Inc.
  • FDA Inspection 1332618 - 2026-08-14
  • FDA Inspection 1278383 - 2025-07-25
  • FDA Inspection 1113974 - 2019-12-18
  • FDA Inspection 1067530 - 2018-09-05
  • FDA Inspection 988732 - 2016-06-15

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Avista Pharma Solutions, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.